Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Patient Acceptance of Health Care × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 11 Breast Neoplasms 9 Neoplasm Metastasis 2 Upper Gastrointestinal Tumours 1 Stomach Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Patient Acceptance of Health Care 1 Pancreatic Cancer Non-resectable 1 Locally Advanced Colorectal Cancer 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 HER-2 Positive Gastric Cancer 1 Frailty 1 Colonic Neoplasms 1

Interventions

palbociclib 1 exemestane 1 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Letrozole 1 Fulvestrant 1 Epirubicin 1 Drug Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡